Exact Mass: 297.10731400000003

Longifolonine

2-Methylguanosine

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(methylamino)-6,9-dihydro-3H-purin-6-one

2-Methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 17336316, 17154124, 3506820, 17044778, 17264127) [HMDB] 2-Methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 17336316, 17154124, 3506820, 17044778, 17264127). N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's. N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's.

1-Methylguanosine

2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methyl-6,9-dihydro-1H-purin-6-one

1-Methylguanosine is a methylated nucleoside. It is known that some modified, especially methylated, nucleosides originating from RNA degradation are excreted in abnormal levels in the urine of patients with malignant tumours. These nucleosides have been proposed as tumour markers. Their measurement could provide a non-invasive diagnostic method, help identify different cancers, and monitor any therapeutic effects (PMID:9129323). 1-Methylguanosine is a methylated nucleoside. It is known that some modified, especially methylated, nucleosides originating from RNA degradation are excreted in abnormal levels in the urine of patients with malignant tumours and they have been proposed as tumour markers. Their 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1]. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1].

3'-O-Methylguanosine

2-amino-9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-6,9-dihydro-3H-purin-6-one

3-O-Methylguanosine is an endogenous methylated nucleoside found in human fluids. Methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, it becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 3506820, 17044778, 17264127, 16799933) [HMDB] 3-O-Methylguanosine is an endogenous methylated nucleoside found in human fluids. Methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, it becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 3506820, 17044778, 17264127, 16799933). 3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].

(S)-Annocherine A

1-[hydroxy(4-hydroxyphenyl)methyl]-6-methoxyisoquinolin-7-ol

(R)-Annocherine A is found in fruits. (R)-Annocherine A is an alkaloid from the leaves of Annona cherimola (cherimoya).

Nelarabine

(2R,3S,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

Nelarabine is only found in individuals that have used or taken this drug. It is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. Nelarabine is a purine nucleoside analog converted to its corresponding arabinosylguanine nucleotide triphosphate (araGTP), resulting in inhibition of DNA synthesis and cytotoxicity.Once nelarabine is metabolized into ara-GTP, the metabolite accumulates in leukemic blasts and incorporates into DNA to exert its S phase-specific cytotoxic effects, leading to the induction of fragmentation and apoptosis. Ara-GTP competes with endogenous deoxyGTP (dGTP) for incorporation into DNA. Once ara-GTP is incorporated at the 3 end of DNA, further DNA elongation is inhibited, which signals apoptosis and leads to cellular destruction. Additional cytotoxic activities may exist, but these are not fully understood. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Nelarabine (506U78) is a nucleoside analogue and can be used for the research of T cell acute lymphoblastic leukemia (T-ALL)[1].

2'-C-Methylguanosine

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-6,9-dihydro-1H-purin-6-one

5-Hydroxymebendazole

methyl N-{5-[hydroxy(phenyl)methyl]-3H-1,3-benzodiazol-2-yl}carbamate

Tritiozine

4-(3,4,5-Trimethoxythiobenzoyl)tetrahydro-1,4-oxazine

Calcium diglutamate

Ethyl 3-methyl-7-oxo-2-phenyl-1H,7H-pyrazolo[1,5-a]pyrimidine-6-carboxylic acid

Flavour enhancer; salt substitute. Calcium diglutamate, sometimes abbreviated CDG and also called calcium glutamate, is a compound with formula Ca(C5H8NO4)2. It is a calcium acid salt of glutamic acid. CDG is a flavor enhancer (E number E623) ? it is the calcium analog of monosodium glutamate (MSG). Because the glutamate is the actual flavor-enahancer, DCG has the same flavor-enhancing properties as MSG, but without the increased sodium content. As a soluble source of calcium ions, this chemical is also used as a first-aid treatment for exposure to hydrofluoric acid. Flavour enhancer; salt substitute

2-O-methylguanosine

2`-O-Methylguanosine

Guanosine with the hydrogen on the hydroxyl at position C-2 substituted with a methyl group. CONFIDENCE standard compound; INTERNAL_ID 318 2'-O-Methylguanosine is a modified nucleoside produced in tRNAs by the action of tRNA guanosine-2’-O-methyltransferase. 2'-O-Methylguanosine results in apoptotic changes of cells[1][2].

5-Hydroxymebendazole

1-[(Benzyloxy)carbonyl]-2-indolinecarboxylic acid

C15H15N5S (297.10481100000004)

Maybridge3_004494

Ethyl 2-cyano-3-[(6-methoxy-8-quinolyl)amino]acrylate

N(6)-OH-Me-Adenosine

consensus spectrum

7-Methylguanosine

2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methyl-6-oxo-6,7-dihydro-3H-1,3,7,9$l^{5}-purin-9-ylium

4xi-hydroxy-(1rC2)-spiro[cyclohexane-1,1-cyclopenta[ij][1,3]dioxolo[4,5-g]isoquinolin]-2-one|scortechiniine B

6-Hydroxygalanthindole

Desmosine[alkaloid]

Adenosine, 2-methoxy-

NSC529863

SCHEMBL14614880

Bagremycin B

MCULE-5651531235

C17H15NO4

Canelillinoxine

piperolactam D

Ac-1-Hydroxy-3-methoxy-10-methylacridone

JANEX-1

4-[(6,7-dimethoxy-4-quinazolinyl)amino]-phenol

Nelarabine

Nelarabine (Arranon)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Nelarabine (506U78) is a nucleoside analogue and can be used for the research of T cell acute lymphoblastic leukemia (T-ALL)[1].

Spongosine

1-methylguanosine

Guanosine substituted with a methyl group at position N-1. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1]. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1].

3-O-Methylguanosine

Guanosine, 3-O-methyl-

Guanosine with the hydrogen on the hydroxyl at position C-3 substituted with a methyl group. 3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].

N2-Methylguanosine

N-Methylguanosine

N(2)-Methylguanosine

CONFIDENCE standard compound; INTERNAL_ID 319 N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's. N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's.

N1-Methylguanosine; LC-tDDA; CE10

N1-Methylguanosine; LC-tDDA; CE20

N1-Methylguanosine; LC-tDDA; CE30

N1-Methylguanosine; LC-tDDA; CE40

7-Methylguanosine; AIF; CE0; CorrDec

7-Methylguanosine; AIF; CE10; CorrDec

7-Methylguanosine; AIF; CE30; CorrDec

7-Methylguanosine; AIF; CE0; MS2Dec

7-Methylguanosine; AIF; CE10; MS2Dec

7-Methylguanosine; AIF; CE30; MS2Dec

N2-Methylguanosine; AIF; CE0; CorrDec

N2-Methylguanosine; AIF; CE10; CorrDec

N2-Methylguanosine; AIF; CE30; CorrDec

N2-Methylguanosine; AIF; CE0; MS2Dec

N2-Methylguanosine; AIF; CE10; MS2Dec

N2-Methylguanosine; AIF; CE30; MS2Dec

N1-Methylguanosine; AIF; CE0; CorrDec

N1-Methylguanosine; AIF; CE10; CorrDec

N1-Methylguanosine; AIF; CE30; CorrDec

N1-Methylguanosine; AIF; CE0; MS2Dec

N1-Methylguanosine; AIF; CE10; MS2Dec

N1-Methylguanosine; AIF; CE30; MS2Dec

7-Methylguanosine; LC-tDDA; CE10

7-Methylguanosine; LC-tDDA; CE20

7-Methylguanosine; LC-tDDA; CE30

7-Methylguanosine; LC-tDDA; CE40

N2-Methylguanosine; LC-tDDA; CE10

N2-Methylguanosine; LC-tDDA; CE20

N2-Methylguanosine; LC-tDDA; CE30

N2-Methylguanosine; LC-tDDA; CE40

N6-Hydroxymethyl-adenosine

Mebendazole metabolite (Carbamic acid, [5-(hydroxyphenylmethyl)-1H-benzimidazol-2-yl]-, methyl ester

3-OMG

Guanosine, 3-O-methyl-

3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].

(S)-Annocherine A

1-[hydroxy(4-hydroxyphenyl)methyl]-6-methoxyisoquinolin-7-ol

Boc-L-Phe chloromethyl ketone

5-OXO-1-(4-PHENOXYPHENYL)PYRROLIDINE-3-CARBOXYLICACID

2-(2-benzoylphenyl)-2-phenylacetonitrile

WHI-P180

4-[3-Hydroxyanilino]-6,7-dimethoxyquinazoline

2-(Biphenyl-4-yl)indolizine-3-carboxaldehyde

4-{3-[3-(Trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}piperidine

C14H14F3N3O (297.108891)

TRANS-TERT-BUTYL 3-FLUORO-4-(METHYLSULFONYLOXY)PIPERIDINE-1-CARBOXYLATE

C11H20FNO5S (297.1046162)

CIS-TERT-BUTYL 3-FLUORO-4-(METHYLSULFONYLOXY)PIPERIDINE-1-CARBOXYLATE

C11H20FNO5S (297.1046162)

Methyl N-[(benzyloxy)carbonyl]-L-methioninate

2-tert-Butoxycarbonylamino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid

2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile

C14H15BF3NO2 (297.1147876)

(R)-TERT-BUTYL (4-CHLORO-3-OXO-1-PHENYLBUTAN-2-YL)CARBAMATE

Ethyl 1-benzyl-5-hydroxy-1,2,3,6-tetrahydro-4-pyridinecarboxylate hydrochloride (1:1)

(S)2,3-DIHYDRO-INDOLE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER

(1-AMINO-PYRROLIDIN-3-YL)-METHANOL

1-(MESITYLSULFONYL)PYRROLIDINE-2-CARBOXYLIC ACID

Fmoc-Gly-OH

Z-L-LEU-CHLOROMETHYLKETONE

1H-Indole-2-carboxylicacid, 5-methoxy-6-(phenylmethoxy)-

4-(toluene-4-sulfonylamino)-cyclohexanecarboxylic acid

Valganciclovir

1-phenylmethoxycarbonyl-2,3-dihydroindole-2-carboxylic acid

8-Acetyl-6-benzyloxy-4H-benzo[1,4]oxazin-3-one

Ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride

Fmoc-Gly-OH-15N

8-acetyl-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one

1,2-diphenyl-1h-indole-3-carbaldehyde

3-METHYL-5-METHOXYCARBONYL-1-BENZYL-4-PIPERIDONE HYDROCHLORIDE

2-isonicotinoyl-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

Ethyl 4-(4-aminophenoxy)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

2H-3-Benzazepin-2-one, 3-(3-chloropropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-

5-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-pyridinamine

4-Cyano-3-fluorophenyl 4-butylbenzoate

C18H16FNO2 (297.1165008)

2-C-Methylguanosine

1-[[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methylpyrrolidinium inner salt

2-BENZAMIDO-3-(4-METHOXYPHENYL)ACRYLIC ACID

n-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1h-purin-2-yl]acetamide

C14H20ClN3S (297.10663900000003)

Methapyrilene Hydrochloride

C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

Boc-GlyP(O)(OMe)2OMe

C10H20NO7P (297.097734)

Ethyl 1-benzyl-4-oxo-3-piperidinecarboxylate hydrochloride

Tritiozine

C10H19NO9 (297.10597640000003)

C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent Trithiozine is an orally active antisecretory and antiulcer agent. Trithiozine can be used for the research of peptic ulcer disease and hypersecretory disorders[1].

Isofagomine D-Tartrate

8-(2R)-Oxiranyl-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one

(2Z)-5,6-Dimethoxy-2-[(1-oxido-4-pyridinyl)methylene]-1-indanone

Toluene-4-sulfonic acid (S)-1-acetyl-pyrrolidin-2-ylMethyl ester

C12H16ClN5O2 (297.09924659999996)

(2-benzylidene-3-oxo-benzofuran-6-yl) acetate

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile

C14H15BF3NO2 (297.1147876)

2-AMINO-3-CARBAMOYL-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRIDINE-6-CARBOXYLIC ACID TERT-BUTYL ESTER

5-phenyl-2-(4-phenylphenyl)-1,3-oxazole

4-(5-Formyl-thiazol-2-yl)-piperazine-1-carboxylic acid tert-butyl ester

C10H19NO9 (297.10597640000003)

Afegostat tartrate

C87006 - Pharmacological Chaperone

2-[[(E)-3-(4-methoxyphenyl)prop-2-enoyl]amino]benzoic acid

N,2-dimethyl-N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]furan-3-carboxamide

N-(3-nitrophenyl)-3,4-dihydro-1H-isoquinoline-2-carboxamide

N7-Methylguanosine

C12H17N4O3S+ (297.10213120000003)

(2s)-2-(4-Chlorophenyl)-2-[4-(1h-Pyrazol-4-Yl)phenyl]ethanamine

C17H16ClN3 (297.1032686)

(2r)-2-(4-Chlorophenyl)-2-[4-(1h-Pyrazol-4-Yl)phenyl]ethanamine

C17H16ClN3 (297.1032686)

3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-3H-pyrrolo[3,2-D]pyrimidin-7-YL)pyrrolidinium

Adenosine, N-(hydroxymethyl)-

Guanosine, 1-methyl-

Aeruginascin(1-)

C13H18N2O4P- (297.1004138)

(E)-4-methyl-6-(3-methyl-1,4-dioxonaphthalen-2-yl)hex-4-enoate

C18H17O4- (297.1126782)

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-1H-purin-6-one

2-[(2-hydroxy-3-methoxyphenyl)methylene]-N-(3-methoxypropyl)hydrazine-1-carbothioamide

3-(2-Methoxy-6-methyl-3-pyridinyl)-5-(2-methoxyphenyl)-1,2,4-oxadiazole

N-(1H-indazol-6-yl)-2,4-dimethoxybenzamide

4-(4-Chloro-2-methylphenoxy)-1-(4-morpholinyl)-1-butanone

8-(1H-indol-3-ylmethylidene)-6,10-dioxaspiro[4.5]decane-7,9-dione

3-(3-methoxyphenyl)-N-(3-pyridinyl)-4,5-dihydroisoxazole-5-carboxamide

1-(4-Methoxyphenyl)-3-(2-methyl-1,3-benzoxazol-5-yl)urea

(Z)-4-[3-(benzylamino)phenyl]-2-hydroxy-4-oxo-but-2-enoic acid

4-Amino-3-cyclohexylcarbamoyl-isothiazole-5-carboxylic acid ethyl ester

Methyl 2-[(2-methoxyacetyl)amino]-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

methyl 2-[(butoxycarbonyl)amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate

1-[(6-chloro-2-imidazo[1,2-a]pyridinyl)methyl]-3,4-dihydro-2H-quinoline

C17H16ClN3 (297.1032686)

2-(D-alanylamino)-N-[(1S)-1-hydroxy-3-mercaptopropyl]benzamide

(5Z)-5-[(2E)-3-(phenylamino)prop-2-en-1-ylidene]-1-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione

Ethyl 2-cyano-3-[(6-methoxyquinolin-8-yl)amino]prop-2-enoate

4-[[6,7-Bis(hydroxymethyl)-4-quinazolinyl]amino]phenol

4-({[3,5-Dimethyl-4-(methylthio)phenoxy]carbonyl}amino)butanoic acid

2-Methoxyadenosine

3-[(Diethoxyphosphinyl)methyl]-5-phenyl-2-isoxazoline

C14H20NO4P (297.112989)

N(2)-Methylguanosine

Guanosine with the hydrogen on the amine at position N-2 substituted with a methyl group.

fusarithioamide A

A member of the class of benzamides that is 2-aminobenzoic acid in which the hydrogen atom of the carboxy group has been substituted by a [(1S)-1-hydroxy-3-mercaptopropyl]nitrilo group and in which one of the the hydrogens of the amino group has been substituted by a (2R)-2-aminopropanoyl group. It is a metabolite isolated from the endophytic fungus, Fusarium chlamydosporium.

2'-O-Methylguanosine

O-Methylguanosine

6-O-Methyl Guanosine

6-O-Methyl Guanosine is a modified nucleoside[1]. 6-O-Methyl Guanosine (6-methylguanosine) inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line[2].

7-Methylguanosine

7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor with IC50 value of 87.8?±?7.5?μM. 7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor with IC50 value of 87.8?±?7.5?μM.

4-{5-[(4-hydroxyphenyl)methyl]-1,2,4-triazol-1-yl}-3-methoxyphenol

3-(4-hydroxy-3,5-dimethoxybenzylidene)-2-indolinone

{"Ingredient_id": "HBIN007476","Ingredient_name": "3-(4-hydroxy-3,5-dimethoxybenzylidene)-2-indolinone","Alias": "NA","Ingredient_formula": "C17H15NO4","Ingredient_Smile": "NA","Ingredient_weight": "297.31","OB_score": "NA","CAS_id": "189098-75-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8488","PubChem_id": "NA","DrugBank_id": "NA"}

alpha-D-Arabinofuranosyladenine

(2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl-; (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 9-alpha-D-Arabinofuranosyladenine; NSC 70422; 6936-84-1; AIDS023910; NSC 40584; 9H-Purin-6-amine, 9-alpha-D-arabinofuranosyl- (9CI); (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl- (8CI); (2S,3S,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS-023910

{"Ingredient_id": "HBIN015484","Ingredient_name": "alpha-D-Arabinofuranosyladenine","Alias": "(2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl-; (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 9-alpha-D-Arabinofuranosyladenine; NSC 70422; 6936-84-1; AIDS023910; NSC 40584; 9H-Purin-6-amine, 9-alpha-D-arabinofuranosyl- (9CI); (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl- (8CI); (2S,3S,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS-023910","Ingredient_formula": "C11H15N5O5","Ingredient_Smile": "C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N","Ingredient_weight": "297.27","OB_score": "20.89729146","CAS_id": "6936-84-1","SymMap_id": "SMIT12080","TCMID_id": "NA","TCMSP_id": "MOL011145","TCM_ID_id": "NA","PubChem_id": "96368","DrugBank_id": "NA"}

annocherine a